Frank Rimerman Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.7M Sell
19,905
-49
-0.2% -$4.44K 0.09% 165
2026
Q2
$1.83M Buy
19,954
+221
+1% +$19.3K 0.1% 155
2026
Q1
$1.68M Buy
19,733
+176
+0.9% +$15.7K 0.11% 149
2025
Q4
$1.55M Buy
19,557
+13,761
+237% +$1.08M 0.1% 161
2025
Q3
$463K Sell
5,796
-2,666
-32% -$227K 0.03% 387
2025
Q2
$769K Buy
8,462
+1,947
+30% +$178K 0.05% 257
2025
Q1
$610K Buy
6,515
+700
+12% +$62.7K 0.05% 279
2024
Q4
$529K Sell
5,815
-43
-0.7% -$4.1K 0.04% 297
2024
Q3
$608K Sell
5,858
-69
-1% -$7.03K 0.04% 294
2024
Q2
$575K Buy
5,927
+5,833
+6,205% +$538K 0.04% 311
2024
Q1
$8.46K Hold
94
– – ﹤0.01% 181
2023
Q4
$7.49K Buy
+94
New +$7.07K ﹤0.01% 180

Other funds holding CL

Frank Rimerman Advisors's CL Position: Q3 2026 in Review

Frank Rimerman Advisors reduced its Colgate-Palmolive (CL) stake by 0.25% in Q3 2026, selling an estimated $4.44K and leaving 19,905 shares worth $1.7M. The position accounts for 0.09% of the portfolio, ranked #165.

Frank Rimerman Advisors first reported a position in CL in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.83M in Q2 2026. 1,212 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Frank Rimerman Advisors held 19,905 shares of Colgate-Palmolive worth $1.7M as of Q3 2026.
  • Frank Rimerman Advisors sold 49 Colgate-Palmolive shares in Q3 2026, an estimated $4.44K.
  • Colgate-Palmolive made up 0.09% of Frank Rimerman Advisors's portfolio in Q3 2026, its #165 holding.
  • Frank Rimerman Advisors first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 12 quarters since.
  • Frank Rimerman Advisors's Colgate-Palmolive position peaked at $1.83M in Q2 2026.
  • 1,212 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.